Adaptive landscape flattening allows the design of both enzyme: Substrate binding and catalytic power.

by Vaitea Opuu, Giuliano Nigro, Thomas Gaillard, Emmanuelle Schmitt, Yves Mechulam, Thomas Simonson
Published 2020-01-01

PD-L1 expression with QR1 and E1L3N antibodies according to histological ovarian cancer subtype: A series of 232 cases

by Caroline Eymerit-Morin, Anna Ilenko, Thomas Gaillard, Justine Varinot, Eva Compérat, Sofiane Bendifallah, Emile Darai
Published 2021-03-01

Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group

by Grégoire Rocher, Thomas Gaillard, Catherine Uzan, Pierre Collinet, Pierre-Adrien Bolze, Marcos Ballester, Sofiane Bendifallah, Lobna Ouldamer, Cyril Touboul, Cyrille Huchon, Vincent Lavoue, Yohann Dabi, Cherif Akladios, Charles Coutant, Emilie Raimond, Alexandre Bricou, Geoffroy Canlorbe, Henri Azaïs
Published 2021-03-01